MYD88 Mutations in Chronic Lymphocytic Leukemia Exhibit Distinct Biological Behaviors and Prognostic Implications

被引：0
|
作者：
Yan, Yuting [1 ]
Zhou, Yulan [2 ]
Chen, Weihao [1 ]
Wang, Jun [3 ]
Wang, Tingyu [1 ]
Yu, Ying [1 ]
Jia, Yujiao [1 ]
Yu, Zhen [1 ]
Qiu, Lugui [1 ]
Li, Eei [4 ]
Yi, Shuhua [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Ctr Hematol, Nanchang, Peoples R China
[3] Natl Clin Res C, State Key Lab Expt Hematol, Tianjin, Peoples R China
[4] Nanchang Univ, Affiliated Hosp 1, Dept Hematol, Nanchang, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-207323
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4624 / 4625
页数：2
相关论文
共 50 条
  • [21] Dealing with complexity: prognostic implications of karyotype and mutations in chronic lymphocytic leukemia
    Grieselhuber, Nicole R.
    Asquith, Justin M.
    Andritsos, Leslie A.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1149 - S1152
  • [22] Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features
    Shuai, Wen
    Lin, Pei
    Strati, Paolo
    Patel, Keyur P.
    Routbort, Mark J.
    Hu, Shimin
    Wei, Peng
    Khoury, Joseph D.
    You, M. James
    Loghavi, Sanam
    Tang, Zhenya
    Fang, Hong
    Thakral, Beenu
    Medeiros, L. Jeffrey
    Wang, Wei
    BLOOD CANCER JOURNAL, 2020, 10 (08)
  • [23] Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features
    Wen Shuai
    Pei Lin
    Paolo Strati
    Keyur P. Patel
    Mark J. Routbort
    Shimin Hu
    Peng Wei
    Joseph D. Khoury
    M. James You
    Sanam Loghavi
    Zhenya Tang
    Hong Fang
    Beenu Thakral
    L. Jeffrey Medeiros
    Wei Wang
    Blood Cancer Journal, 10
  • [24] Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia
    Diop, Fary
    Moia, Riccardo
    Favini, Chiara
    Spaccarotella, Elisa
    De Paoli, Lorenzo
    Bruscaggin, Alessio
    Spina, Valeria
    Terzi-di-Bergamo, Lodovico
    Arruga, Francesca
    Tarantelli, Chiara
    Deambrogi, Clara
    Rasi, Silvia
    Adhinaveni, Ramesh
    Patriarca, Andrea
    Favini, Simone
    Sagiraju, Sruthi
    Jabangwe, Clive
    Kodipad, Ahad A.
    Peroni, Denise
    Mauro, Francesca R.
    Del Giudice, Ilaria
    Forconi, Francesco
    Cortelezzi, Agostino
    Zaja, Francesco
    Bomben, Riccardo
    Rossi, Francesca Maria
    Visco, Carlo
    Chiarenza, Annalisa
    Rigolin, Gian Matteo
    Marasca, Roberto
    Coscia, Marta
    Perbellini, Omar
    Tedeschi, Alessandra
    Laurenti, Luca
    Motta, Marina
    Donaldson, David
    Weir, Phil
    Mills, Ken
    Thornton, Patrick
    Lawless, Sarah
    Bertoni, Francesco
    Del Poeta, Giovanni
    Cuneo, Antonio
    Follenzi, Antonia
    Gattei, Valter
    Boldorini, Renzo Luciano
    Catherwood, Mark
    Deaglio, Silvia
    Foa, Robin
    Gaidano, Gianluca
    HAEMATOLOGICA, 2020, 105 (02) : 448 - 456
  • [25] Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia
    C Baer
    F Dicker
    W Kern
    T Haferlach
    C Haferlach
    Leukemia, 2017, 31 : 1355 - 1362
  • [26] Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia
    Baer, C.
    Dicker, F.
    Kern, W.
    Haferlach, T.
    Haferlach, C.
    LEUKEMIA, 2017, 31 (06) : 1355 - 1362
  • [27] Targeting IRAK4 disrupts inflammatory pathways and tumor microenvironment in chronic lymphocytic leukemia regardless MYD88 mutational status
    Rosich, Laia
    Gimenez, Neus
    Schulz, Ralph
    Higashi, Morihiro
    Aymerich, Marta
    Lopez, Monica
    Juan, Manel
    Seiffert, Martina
    Campo, Elias
    Colomer, Dolors
    CANCER RESEARCH, 2018, 78 (13)
  • [28] Perspectives on Precision Medicine in Chronic Lymphocytic Leukemia: Targeting Recurrent Mutations-NOTCH1, SF3B1, MYD88, BIRC3
    Putowski, Maciej
    Giannopoulos, Krzysztof
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [29] Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications
    Perez-Carretero, Claudia
    Hernandez-Sanchez, Maria
    Gonzalez, Teresa
    Quijada-Alamo, Miguel
    Martin-Izquierdo, Marta
    Hernandez-Sanchez, Jesus-Maria
    Vidal, Maria-Jesus
    de Coca, Alfonso Garcia
    Aguilar, Carlos
    Vargas-Pabon, Manuel
    Alonso, Sara
    Sierra, Magdalena
    Rubio-Martinez, Araceli
    Davila, Julio
    Diaz-Valdes, Jose R.
    Queizan, Jose-Antonio
    Hernandez-Rivas, Jose-angel
    Benito, Rocio
    Rodriguez-Vicente, Ana E.
    Hernandez-Rivas, Jesus-Maria
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (10) : 2780 - 2792
  • [30] Chronic Lymphocytic Leukemia Patients with IGH Rearrangements Are Characterized By a Distinct Genetic Landscape with Prognostic Implications
    Perez Carretero, Claudia
    Hernandez-Sanchez, Maria
    Gonzalez, Teresa
    Quijada Alamo, Miguel
    Martin Izquierdo, Marta
    Hernandez-Sanchez, Jesus M.
    Santos-Minguez, Sandra
    Vidal, Maria-Jesus
    Garcia de Coca, Alfonso
    Aguilar, Carlos
    Vargas-Pabon, Manuel
    Alonso, Sara
    Sierra, Magdalena
    Rubio-Martinez, Araceli
    Davila, Julio
    Diaz-Valdes, Jose R.
    Antonio Queizan, Jose
    Angel Hernandez-Rivas, Jose
    Mateos, Maria-Victoria
    Benito, Rocio
    Rodriguez, Ana E.
    Hernandez-Rivas, Jesus-Maria
    BLOOD, 2018, 132
12345